Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alessandro Bartoloni and Alessandro Morettini.
Alessandro Bartoloni
Connection Strength
0.573
Alessandro Morettini
  1. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy. Int J Infect Dis. 2021 Jul; 108:231-236.
    View in: PubMed
    Score: 0.235
  2. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients. Eur J Immunol. 2020 Dec; 50(12):2013-2024.
    View in: PubMed
    Score: 0.057
  3. Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection. Immunology. 2020 12; 161(4):345-353.
    View in: PubMed
    Score: 0.057
  4. Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study. BMJ Open. 2020 09 25; 10(9):e040729.
    View in: PubMed
    Score: 0.057
  5. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
    View in: PubMed
    Score: 0.056
  6. Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
    View in: PubMed
    Score: 0.055
  7. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy. Thromb Haemost. 2020 08; 120(8):1233-1236.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.